Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TransMedics Group, Inc. Director's Dealing 2023

Dec 15, 2023

31201_dirs_2023-12-15_61189cfc-9b92-4b7d-a4ec-45a8c7ea77e1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2023-12-13

Reporting Person: Provost Miriam (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-13 Common Stock M 415 $16.14 Acquired 24026 Direct
2023-12-13 Common Stock S 206 $75.10 Disposed 23820 Direct
2023-12-13 Common Stock M 1632 $66.10 Acquired 25452 Direct
2023-12-13 Common Stock S 1509 $75.10 Disposed 23943 Direct
2023-12-13 Common Stock M 3597 $38.46 Acquired 27540 Direct
2023-12-13 Common Stock S 2407 $75.10 Disposed 25133 Direct
2023-12-15 Common Stock G 1785 $0.00 Disposed 23348 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-12-13 Stock Option (Right to Buy) $16.14 M 415 Disposed 2030-02-27 Common Stock (415) Direct
2023-12-13 Stock Option (Right to Buy) $66.10 M 1632 Disposed 2033-02-20 Common Stock (1632) Direct
2023-12-13 Stock Option (Right to Buy) $38.46 M 3597 Disposed 2031-02-24 Common Stock (3597) Direct

Footnotes

F1: The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.

F2: On December 15, 2023, the reporting person donated 1,785 shares of directly owned common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.

F3: Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F4: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.

F5: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 20, 2023.

F6: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.